Home › Narcolepsy › Pennsylvania
Narcolepsy clinical trials in Pennsylvania
4 studies for Narcolepsy are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Wyomissing
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 3, 2026 · NCT07455383A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
- Abington Neurological Associates, Abington
- Geisinger Medical Center, Danville
- University of Pittsburgh, Pittsburgh
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT07675135A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Abington
- Alkermes Investigational Site, Wyomissing
RecruitingPhase 2/3
Ages 18 to 70 · All sexes · Updated Aug 7, 2026 · NCT06767683A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Abington, Pennsylvania, Abington
- Willow Grove, Pennsylvania, Willow Grove
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Apr 16, 2026 · NCT07096674From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.